Shares of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) dropped by as much as 47% in early trading Monday. The reason?
In looking at today’s take on the bulls and the bears a.k.
Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) investors have a smile on their faces Friday morning, after the healthcare firm announced that the FDA has permitted the …